Citations

Clear

1056 citation(s) found for "Sharma, N".

Predictors of Long-Term Outcomes in Hypertrophic Cardiomyopathy
Investigators, The HCMR, Kolm, Paul, DiMarco, John P., Desai, M Y, Ho, Carolyn Y., Kwong, Raymond Y., Dolman, Sarahfaye , Nickens, Patrice Desvigne, GELLER, NANCY, Kim, Dong-Yun, Schulz-Menger, Jeanette, Friedrich, M G, Maron, Martin S., Appelbaum, Evan, Francis, Gary S., Greenberg, Barry, Jerosch-Herold, Michael, Piechnik, Stefan, Mahmod, Masliza, Jacoby, Daniel L., Baldassare, Lauren A., White, J, Helms, Adam S., Choudhury, Lubna , Michels, Michelle, Salerno, Michael , Heitner, Steven B., Masri, Ahmad, Prasad, Sanjay , Plein, S V E N, Madias, Christopher, Mahrholdt, Heiko , Bucciarelli-Ducci, C, Nightingale, Angus K. , Weinsaft, Jonathan W., McCann, Gerry P., Rossum, Albert van, Germans, Tjeerd , Williamson, Eric E. , Geske, Jeffrey B., Dawson, D, Mongeon, François‐Pierre , Olivotto, Iacopo, Crean, Andrew , Woo, Anna, Owens, Anjali T., Anderson, L , Biagini, Elena, Newby, David E., Andre, Florian, Berry, C, Kim, Bette, Larose, Eric, Abraham, Theodore P., Sherrid, Mark V., Gelfand, Eli V. , Nagueh, Sherif F. , Rimoldi, Ornella, Camici, Paolo, Elstein, Eleanor , Watkins, Hugh, Weintraub, William S., Neubauer, Stefan, Schulz‐Menger, Jeanette , Nightingale, Angus K , Dawson, Dana , Kramer, Christopher M. , Kolm, Paul , Desai, Milind Y. , Ho, Carolyn Y. , Kwong, Raymond Y.K. , Desvigne‐Nickens, Patrice , Kim, Dong-Yun, Friedrich, Matthias G. , Maron, Martin S. , Appelbaum, Evan A., Link, Mark S. , Greenberg, Barry, Jerosch‐Herold, Michael , Piechnik, Stefan Kazimierz , Mahmod, Masliza , Raman, Betty , Jacoby, Daniel Louis , Baldassarre, Lauren A. , White, James A. , Chiribiri, Amedeo , Helms, Adam S. , Michels, Michelle , Bradlow, William M. , Heitner, S B, Masri, Ahmad , Mohiddin, Saidi , Plein, Sven , Madias, Christopher A. , Bucciarelli‐Ducci, Chiara , Weinsaft, Jonathan W. , Kim, Han W. , McCann, Gerry P , Rossum, Albert C. van , Geske, Jeffrey B. , Flett, Andrew S. , Olivotto, Iacopo , Woo, Anna, Owens, Anjali , Sharma, Sanjay , Biagini, Elena , Newby, David E. , André, Florian , Berry, Colin , Larose, Éric , Abraham, Theodore P. , Hays, Allison G , Sherrid, Mark V. , Rimoldi, Ornella , Camici, Paolo G. , Autore, Camillo , Watkins, Hugh , Weintraub, William S. , Neubauer, Stefan

Mayo Clinic

JAMA | May 11, 2026 | Volume: 335 | Issue: 22 | Pages: 1959

10.1001/jama.2026.5633 | PMID 42113540 Get It

Importance Current risk prediction guidelines for hypertrophic cardiomyopathy predict only sudden cardiac death and are imperfect, leading to avoidable deaths and unnecessary implantable cardioverter defibrillators. Objective To combine prospectively collected clinical history, imaging, genetic, and biomarker data to improve risk prediction of adverse events in hypertrophic cardiomyopathy. Design, Setting, and Participants A total of 2750 patients with hypertrophic cardiomyopathy were prospectively enrolled in the registry-based study from 44 sites in North America and Europe with expertise in hypertrophic cardiomyopathy and cardiac magnetic resonance (CMR) imaging. Participants were enrolled from April 1, 2014, to April 7, 2017. Exposures Patients underwent a health history questionnaire, blood sampling for biomarkers and genotyping, and contrast-enhanced CMR. Patients were followed up yearly by telephone and through records review regarding event documentation. Main Outcomes and Measures The predefined composite adjudicated primary end point was time to first event for hypertrophic cardiomyopathy–related deaths; nonfatal sustained ventricular arrhythmias (VAs) requiring cardioversion or defibrillation; and left ventricular (LV) assist device implant or heart transplant. A secondary end point was a composite of sudden cardiac death and nonfatal VA events. The elastic-net method identified the most important predictors. Cox proportional hazards regression assessed associations with time to the first end point. Results Of the 2750 prospectively enrolled patients, 2698 (98%) had analyzable data after 9 were excluded because they had hypertrophic cardiomyopathy phenocopies and 43 withdrew. Of these remaining patients, 1919 (71%) were male, mean age was 50 years (SD, 11 years), and 423 (16%) were from underrepresented racial and minority groups. The mean follow-up was 6.9 years (SD, 2.1 years). The primary event model in 104 patients included LV scar as a percentage of LV mass by late gadolinium enhancement (LGE%; hazard ratio [HR], 1.86; 95% CI, 1.58-2.20; P < .001), LV mass index (HR, 1.09; 95% CI, 1.01-1.17; P = .03), LV end-systolic volume index (HR, 1.28; 95% CI, 1.12-1.46; P < .001 ), all per 10-unit increase, history of heart failure at study entry (HR, 2.89; 95% CI, 1.75-4.77; P < .001), and log N-terminal pro–B-type natriuretic peptide (NT-proBNP; HR, 1.41; 95% CI, 1.17-1.70; P < .001) level per log unit, (C index for all, 0.77). An LGE percentage of the LV mass of 9% or higher substantially increased the primary composite event rate ( P = .001). The secondary sudden cardiac death and VA risk factor model (in 69 patients) included LGE%, LV mass index, LV ejection fraction, and log(NT-proBNP) (C index, 0.76). Conclusions and Relevance These results provide prospective evidence for incorporating cardiac magnetic resonance and NT-proBNP in the evaluation of patients with hypertrophic cardiomyopathy. Trial Registration ClinicalTrials.gov Identifier: NCT01915615
Ventricular conduction is a marker for arrhythmic risk in SCN5A- E1784K overlap sodium channel disease
Tanck, Michael W.T. , Wijeyeratne, Yanushi D. , Barc, Julien , Muir, A.J.L., Aiba, Takeshi , Bos, Martijn, Veltmann, Christian , Galvin, Joseph , Crotti, Lia , Ishikawa, Taisuke , Ohno, Seiko , Page, Stephen P, Denjoy, I, Tester, David J. , Muggenthaler, Martina, Takahashi, Kazuhiro , GOURRAUD, JEAN BAPTISTE, Haglund-Turnquist, Carla, Pedrazzini, Matteo , Alberio, Chiara , Petzer, Edward, Roden, Dan M. , Borggrefe, Martin , Ackerman, Michael J. , McKeown, Pascal , Behr, Elijah R. , Bos, J. Martijn , Bos, Johan M , Denjoy, Isabelle , Raju, Hariharan , Gourraud, Jean-Baptiste , Redon, Richard , Jacques Schott, Jean , Pedrazzini, Matteo , Alberio, Chiara , Dagradi, Federica , Papadakis, Michael , Sharma, Sanjay , Petzer, Edward , Roden, Dan M. , Horie, Minoru , Schwartz, Peter J. , Makita, Naomasa , Borggrefe, Martin , Shimizu, Wataru , Probst, Vincent , Behr, Elijah Raphael , Ishikawa, Taisuke , Crotti, Lia , Tanck, Michael , Barc, Julien , Aiba, Takeshi , Veltmann, Christian , Galvin, Joseph , Ohno, Seiko , Denjoy, Isabelle , Muggenthaler, Martina, Gourraud, Jean‐Baptiste , Redon, Richard , Schott, Jean‐Jacques , Haglund-Turnquist, Carla , Dagradi, Federica

Mayo Clinic

Europace | May 9, 2026 | Volume: 28 | Issue: 6 | Pages: No page available

10.1093/europace/euag113 | PMID 42114100 Get It

Abstract Aims SCN5A-E1784K (c.5350G>A) is the most common variant associated with the long QT (LQTS) and Brugada syndromes (BrS). It can manifest variably as LQTS, BrS, and/or conduction disorders. This presents a challenge for risk stratification. We aimed to describe clinical and ECG characteristics and identify risk markers that associate with arrhythmic events. Methods and results We undertook a retrospective observational multicentre study of a large cohort of 231 subjects with SCN5A-E1784K from Europe, USA, and Japan. Comprehensive demographic and clinical data, including initial presentation ECG and follow-up, were collected. ‘Lethal events’ were defined as sudden death, non-fatal cardiac arrest, and documented sustained VT or VF. ‘Cardiac events’ were defined as arrhythmic syncope plus any lethal events. Clinical characteristics and ECG parameters corrected for age were investigated for association with lethal and/or cardiac events. Fourteen (6%) subjects experienced a lethal event and 45 (19%) a cardiac event. PR interval and QRS duration were associated with lethal and cardiac events. In multivariable models, both PR interval and QRS duration were associated with lethal events, but only QRS duration was associated with cardiac events. Only age-corrected QRS (rQRS) was associated with lethal and cardiac event-free survival from birth after correction for multiple testing. Conclusion Ventricular myocardial conduction appears likely to play a role in the risk of arrhythmic events in patients with SCN5A-E1784K. This provides an important opportunity for the personalization of management and has the potential to guide preventative therapies.
Clostridioides difficile infection in inflammatory bowel disease: an observational study in flares of ulcerative colitis and a South Asian region-specific systematic review and meta-analysis
Pahil, Sapna , Chatterjee, Abhirup, Kaur, Simran , Mandavdhare, Harshal S., Shah, Jimil , Raut, Sandeep , Khanna, Sahil , Sinha, Saroj Kant, Taneja, Neelam, Dutta, Usha, Khanna, S , Sharma, Vishal , Bansal, Deepak , Chatterjee, Abhirup , Mandavdhare, Harshal Surendra , Jearth, Vaneet , Sekar, Aravind , Singh, Harjeet , Sinha, Saroj Kant, Taneja, Neelam , Dutta, Usha , Sharma, Vishal

Mayo Clinic

Therapeutic Advances in Gastroenterology | May 7, 2026 | Volume: 19 | Issue: No issue available | Pages: No page available

10.1177/17562848261446520 | PMID 42136876 Get It

Background: Clostridioides difficile infection (CDI) is well-recognised as a cause of flare in inflammatory bowel disease (IBD). Objectives: To prospectively evaluate CDI as a cause of flare in moderate-to-severe ulcerative colitis (UC) and perform a region-specific systematic review to evaluate the role of CDI in IBD patients in South Asia. Design: A single-centre prospective observational study followed by a region-specific systematic review. Data sources and methods: The observational study was conducted between December 2024 and December 2025 and included patients with moderate-to-severe UC flares. Triple testing using Stool glutamate dehydrogenase (GDH), an enzyme immunoassay (EIA) for toxin A/B, and polymerase chain reaction (PCR) testing was performed. A literature search in PubMed, Embase, and Scopus was conducted on 5th December 2025 to identify relevant studies from South Asia. Information on the study population (IBD type, age, gender, disease activity), the testing method, and the outcomes of CDI testing were extracted. The pooled prevalence of CDI was estimated using a random-effects model. The risk of Bias was assessed using Joanna Briggs’ tool. Results: Of the 101 patients with active UC, 59 had acute severe UC. Six patients tested positive for GDH, whereas only one tested positive for EIA and PCR. A total of 13 studies reporting on 1267 patients were included in the systematic review. Pooled prevalence of CDI was 0.06 (0.03–0.11, I 2 = 80.8%). Subgroup analyses were performed by testing method, study type, and region. However, there was persistent statistical heterogeneity. Funnel plot and Egger’s test suggested the presence of publication bias. Conclusion: Our observational study shows a low prevalence of CDI as a cause of UC flares. The findings of the systematic review suggest high variability in the CDI positivity across South Asia. These differences were not fully explained by the method of testing, the type of study, or the geographic location of the study.
Soluble Thrombomodulin Links Viremia and Mortality During COVID‐19: Results From the ACTIV‐4a Trial
Zuchelkowski, Benjamin E. , Inman, Kyle, Nouraie, S Mehdi, Beru, Neeharika, Naqvi, Asma , Qin, Shulin, Yeh, Calvin H., Zhang, Yingze , Shah, Faraaz , Sharma, Lokesh , Zhang, Lianghui , Morris, Alison, Kim, Paul Y., Jacobs, Jana L. , Nouraie, Mehdi , Inman, Kyle W , Nouraie, Seyed Mehdi , Shah, Faraaz A , Zhang, Lianghui , McVerry, Bryan J , Morris, Alison , Neal, Matthew D , Seheult, Jansen N , Kitsios, Georgios D , Mellors, John W , Lawrence, Daniel A , Kim, Paul Y , Jacobs, Jana L , Bain, William G , Zhang, Yingze , Inman, Kyle , Naqvi, Asma , Qin, Shulin , Yeh, Calvin H., Sharma, Lokesh , Dela Cruz, Charles S , Seheult, Jansen N.

Mayo Clinic

Journal of the American Heart Association | May 6, 2026 | Volume: 15 | Issue: 10 | Pages: No page available

10.1161/jaha.125.047693 | PMID 42089155 Get It

Background COVID‐19 and other respiratory viral infections can cause cardiovascular complications. SARS‐CoV‐2 virions are found in the blood, and circulating viral RNA levels are associated with death. We hypothesized that viremia can induce thrombotic endotheliopathy that contributes to death and studied this relationship in patients hospitalized for COVID‐19 and enrolled in the ACTIV‐4a (Accelerating COVID‐19 Therapeutic Interventions and Vaccines) randomized trial of antithrombotic therapy. Methods We quantified SARS‐CoV‐2 nucleocapsid RNA and protein in plasma and measured their associations with clinical outcomes and biomarkers of thromboinflammation and endotheliopathy. We used Cox regression and Fine–Gray competing risk models to analyze survival and thrombosis. We conducted causal mediation analysis to explore whether thrombotic endotheliopathy mediates the relationship between viral RNA and death. Results In 93 patients, SARS‐CoV‐2 RNA and N‐antigen were higher in nonsurvivors. Baseline viral RNA levels were associated with increased 90‐day death (hazard ratio [HR], 1.31 [95% CI, 1.17–1.46]) and thrombosis (HR, 1.35 [95% CI, 1.24–1.47]). Viral RNA more effectively predicted survivorship than N‐antigen levels. Soluble thrombomodulin, a biomarker of thrombotic endotheliopathy, positively correlated with viral RNA levels. Mediation analysis revealed that soluble thrombomodulin accounts for 12.2% (95% CI, 0.1%–32.3%; P =0.048) after adjustment for age and sex of the relationship between viral RNA and the 90‐day mortality rate. Conclusions Elevated plasma SARS‐CoV‐2 RNA levels are associated with death in ACTIV‐4a, which is causally mediated in part by soluble thrombomodulin. We propose that lung–blood viral dissemination is a potential mechanism for cardiovascular complications of respiratory viruses. Registration URL: https://www.clinicaltrials.gov ; Unique Identifier: NCT04505774.
Abstract TU205: The Effect of Physical Activity on the Gut Microbiome in Prediabetes: Results from a Randomized Controlled Trial
Demmer, Ryan, Pope, Zachary, Avenido, Francis Ryan, Mitchell, Nathan, Hubbard, Paige Richmond, Johnson, Stephen, McDonough, DJ, Rydell, Sarah, Johnson, Abigail, Pereira, Mark, Demmer, Ryan T. , Pope, Zachary , Mitchell, Nathan R , Hubbard, Paige F. Richmond, Johnson, Stephen, Sharma, Shweta , Rydell, Sarah A.

Mayo Clinic

Circulation | April 30, 2026 | Volume: 153 | Issue: Suppl_1 | Pages: No page available

10.1161/cir.153.suppl_1.tu205 Get It

Objective: To test the effect of physical activity on the gut microbiome and circulating short chain fatty acids among sedentary overweight/obese adults with prediabetes. We hypothesized that randomization to increased physical activity would result in gut microbiome changes. Methods: \We randomized 77 adults with prediabetes and a sedentary lifestyle into one of two groups: 1) Intervention Group: Invited to engage in home-based moderate intensity walking 3x/week for 30 minutes/session in weeks 1-4 and for 45 minutes/session during weeks 5-8 of the 8-week intervention; or 2) Control Group: Maintained habitual physical activity levels. We performed metagenomic sequencing from stool collected at baseline, week 4, and week 8, with short-chain fatty acids (SCFA) measured from serum collected at baseline and week 8. Taxonomic and functional profiling were performed on the metagenomic reads; alpha diversity metrics were subsequently derived. Linear regression assessed the difference in change between the intervention and control groups for alpha-diversity and SCFA levels. Results: We screened 1,533 participants for eligibility and consented 132. Of these, 87 entered the run-in phase and 77 were randomized. Participants were 51.4±8.9 years old, 87.7% female, and 74% non-Hispanic White. Mean fasting glucose was 103.3±13.2 while mean BMI was 34.4±5.7. In comparison to the control group, the intervention group experienced decreased alpha diversity as characterized by Shannon, Richness, and Faith’s diversity indices by week 8 of the intervention (P<0.05). SCFA levels trended towards improvement in the intervention group, but the results were not statistically significant. Functional analysis of KEGG ontologies revealed themes consistent with a microbiome with enhanced metabolic activity and host-relevant metabolic signaling (Figure). Conclusions: Randomization to a walking intervention resulted in modest gut microbiome changes among adults with overweight/obesity and prediabetes.
Abstract TH902: Joint Impact of Social Determinants of Health Burden and Coronary Artery Disease on All-Cause and Cardiovascular Mortality: 18-Year Follow-up From National Health And Nutrition Examination Survey 2000–2018
Nizam, Muhammad, Kamel, Omar, Goel, Anika, Sharma, Grishma , Adusumilli, Devika , Gohar, Najam , Ahmed, Faizan, Goel, Anika , Ahmed, Faizan , Shahid, Izza

Mayo Clinic

Circulation | April 30, 2026 | Volume: 153 | Issue: Suppl_1 | Pages: No page available

10.1161/cir.153.suppl_1.th902 Get It

Background: Coronary heart disease (CHD) remains the leading cause of death in the United States, yet the benefits of modern cardiovascular care are not equitably distributed. Social determinants of health (SDoH), which includes economic stability, education, healthcare access, and neighborhood environment, may substantially shape outcomes among patients with CHD. Our study evaluates the joint association of SDoH burden and CHD with mortality outcomes. Methods: We analyzed adults ≥20 years from the National Health and Nutrition Examination Survey (NHANES) 2000–2018, linked with the National Death Index through 2018. Cumulative SDoH burden was derived from eight domains (employment, poverty-to-income ratio, food insecurity, education, healthcare access, insurance, housing, marital status), categorized as low (0–2), moderate (3–5), or high (6–8). Weighted Cox proportional hazards models estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for all-cause and cardiovascular mortality by SDoH burden, stratified by CHD status, with sequential adjustment for demographic and cardiometabolic factors. Results: Among 49.3 million U.S. adults (mean age 46.1 ± 15.6 years; 44.8% female), 3.7% had CHD. Those with CHD were older (64.7 vs 45.4 years, p < 0.001), more often non-Hispanic White (94.2% vs 81.5%), and had greater waist circumference (106.1 vs 87.5 cm) but lower cholesterol (176 vs 202 mg/dL, p < 0.001). Participants with high SDoH burden had lower income and education. In weighted regression, higher SDoH burden and CHD were independently associated with greater all-cause and cardiovascular mortality. Fully adjusted models showed high SDoH burden tripled all-cause mortality risk (HR 3.00, p < 0.001), while CHD further amplified risk. Compared with low SDoH/no CHD, those with CHD and high SDoH burden had nearly a 14-fold higher all-cause mortality (HR 13.6, p < 0.001) and 17-fold higher cardiovascular mortality (HR 17.7, p < 0.001). Findings were consistent across sex, race, and metabolic subgroups, with mortality hazards often exceeding tenfold among those with both CHD and high SDoH burden. Conclusions: Cumulative SDoH burden is strongly and independently associated with mortality among adults with CHD, with evidence of a synergistic effect between biological and social vulnerability. These findings underscore the need for policies and interventions addressing upstream social inequities to improve survival in cardiovascular populations.
Are Circulating Tumor DNA and Urinary Tumor DNA the New PSA for Clinically Localized Muscle-Invasive Bladder Cancer in the Enfortumab Vedotin/Pembrolizumab Era?
Li, Eric V. , Sharma, Vidit, Boorjian, Stephen A, Sharma, Vidit , Boorjian, Stephen A.

Mayo Clinic

Journal of Urology | April 29, 2026 | Volume: 216 | Issue: 3 | Pages: 324-326

10.1097/ju.0000000000005074 | PMID 42054606 Get It

Psychological stress affecting the size and resolution of an intermittent post-traumatic vascular lesion of the temporalis muscle
Arora, Harshit , Sharma, Vasudha , Arora, Lavanya, Singh, Waryaam , Pasricha, Rajesh , Singh, Waryaam , Arora, Lavanya, Pasricha, Rajesh

Mayo Clinic

Jornal Vascular Brasileiro | April 27, 2026 | Volume: 25 | Issue: No issue available | Pages: No page available

10.1590/1677-5449.202501052 | PMID 42094717 Get It

Abstract Vascular anomalies are disorders of arteries or veins which are further sub-classified as vascular malformations or vascular tumors. Vascular malformations are attributed to disorderly vascular morphogenesis, trauma, or hormonal imbalances. We present a rare case of a patient in their 30s who presented to the outpatient department with a localized post-traumatic soft tissue swelling in the temporalis region, which was soft and non-pulsatile with occurrences in periods of acute emotional stress, followed by spontaneous resolution when the same was negated by the patient. The diagnosis was established on the basis of magnetic resonance imaging and contrast enhanced computed tomography. We add to the existing limited literature on intramuscular vascular malformations of the temporalis muscle and highlight the effect of emotional stress and anxiety on vascular anomalies.
Intrinsically disordered N-terminal and structured DNA-binding domains jointly regulate progesterone receptor transcriptional condensates
Raluy, Louna, Saul, Dominik , Romero-Aristizabal, Catalina , Requena, Borja , Llobet-Cucalon, Lara De , Kosinsky, Robyn Laura , Youssef, Nadine , Garcia‐Cabau, Carla , Lewenstein, Maciej , Salvatella, Xavier , Torreño-Pina, Juan A. , Sharma, Priyanka , Kosinsky, Robyn Laura , Saul, Dominik , Llobet, Lara de , Muñoz-Gil, Gorka , Parajo, M.F. Garcia

Mayo Clinic

No container title available | April 24, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.04.21.719910 Get It

Abstract Transcriptional condensates (TCs) are dynamic, membrane-less assemblies of proteins and nucleic acids that form at specific genomic loci to control gene expression. The primary drivers of TC formation and function are long stretches of polypeptide chains that lack well-defined tertiary structure, known as the intrinsically disordered regions (IDRs) of Transcription Factors (TFs). However, the role of well-structured domains such as the DNA-binding domain (DBD) in condensate formation and downstream regulation remains poorly understood. Here, we investigated whether the DBD of the Progesterone Receptor (PR), a model TF regulated by hormone binding, contributes to the formation of PR TCs. By combining Single Particle Tracking (SPT) with deep-learning-based single-trajectory analysis, we demonstrated that both the IDR and the DBD are required for the formation of PR condensates. Furthermore, transcriptomic analysis showed that mutations of either of the two domains result in the expression of a distinct set of genes, with functional assays corroborating these findings and linking domain-specific transcription to differential effects on cell proliferation and migration. Together, our results show that domains beyond IDRs also play a role in TC formation and function and uncover domain-specific regulation of transcriptional and oncogenic programs.
Monitored anaesthesia care without endotracheal intubation and general anaesthesia in pulsed field atrial fibrillation ablation
Wang, Weijia , Goel, Swecha, Estrada, Susan J, Hwang, Elliot , Obholz, Jacob, Dai, Qiying , Vidaillet, Humberto, Sharma, Param , Wang, Weijia , Kumar, Sanjay

Mayo Clinic

European Heart Journal Open | April 23, 2026 | Volume: 6 | Issue: 2 | Pages: No page available

10.1093/ehjopen/oeag070 | PMID 42125026 Get It

Abstract Aims Pulsed field ablation for atrial fibrillation offers shorter procedural times and improved safety compared with thermal ablation, but the optimal anaesthesia strategy remains uncertain. Most centres in the USA use general anaesthesia with endotracheal intubation, whereas monitored anaesthesia care without endotracheal intubation may be a safe and efficient alternative. Objectives To compare procedural efficiency and safety between monitored anaesthesia care and general anaesthesia for pulsed field ablation. Methods and results Consecutive adults who underwent pulsed field ablation for atrial fibrillation between 2024 and 2025 at Marshfield Clinic Health System were included. The anaesthesia approach was determined by operator preference. Procedural times, medication use, complications, and patient tolerance were recorded prospectively. Among 200 patients, 100 received monitored anaesthesia care without endotracheal intubation, and 100 received general anaesthesia. The mean age was 67 years, 42% were female, and the mean body mass index was 33 kilograms per square metre. Monitored anaesthesia care shortened case duration (77 vs. 95 min; P &lt; 0.001) and laboratory time (118 vs. 153 min; P = 0.002) and required fewer adjunct medications (P &lt; 0.001). Twenty-five procedures (25%) were challenging due to cough or motion but were all completed safely. Complications occurred in one monitored anaesthesia care case and six general anaesthesia cases (P = 0.054). Pulmonary vein isolation was achieved in all patients. Conclusion Monitored anaesthesia care without endotracheal intubation was safe, efficient, and resource-sparing compared with general anaesthesia for pulsed field atrial fibrillation ablation.